[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556140":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":28,"centralContacts":32,"locations":10,"responsibleParty":41,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":61,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"patients will receive oral iron in alternate day regimen",null,"50 patients will receive oral ferrous sulphate in alternate day regimen",[13],"Drug: Ferrous sulfate",{"label":15,"type":10,"description":16,"interventionNames":17},"patients will receive oral iron in single daily dose regimen","50 patients will receive oral ferrous sulphate in single daily dose regimen",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"patients will receive oral iron in thrice daily dose regimen","50 patients will receive oral ferrous sulphate in thrice daily dose regimen",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DRUG","Ferrous sulfate","all patients will receive 200 mg elemental iron (ferrous sulphate)",[9,15,19],[29],{"name":30,"affiliation":5,"role":31},"Farrag S Mohamed","STUDY_CHAIR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Farrag S Mohamed, MD","CONTACT","0201064274671","faragsayed99@gmail.com",{"name":39,"role":35,"phone":10,"phoneExt":10,"email":40},"Youmna Refaat, Professor","yomna-rm@gmail.com",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Farrag Sayed Mohamed","Clinical physician","100556140","different-oral-iron-dosing-regimens-in-treatment-of-iron-deficency-anemia-in-patients-with-chronic-kidney-disease-100556140",false,"NCT06521216","Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease","Comparing Different Oral Iron Dosing Regimens in Treatment of Iron Deficiency Anemia in Patients With Chronic Kidney Disease","Inclusion Criteria:\n\n* All adult patients above 18 years old with CKD stages 2,3 and 4\n\nExclusion Criteria:\n\n* CKD stage 5 (eGFR below 15 ).\n* Patients with hemolytic anemias.\n* Chronic liver diseases .\n* Autoimmune diseases.\n* Malignancy\n* History of blood transfusion last 3 months before the study\n* Pregnancy\n* Adult polycystic kidney disease ( APCKD)","ALL","18 Years",{"count":55,"type":56},150,"ESTIMATED","OBSERVATIONAL","Comparing between the efficacy of alternate day oral iron dose, once daily and thrice daily dose in improving anemia in CKD patients",[60],"CKD","NOT_YET_RECRUITING","2024-07-24",{"date":64,"type":65},"2024-07-25","ACTUAL",{"date":67,"type":56},"2024-08-01",{"date":69,"type":56},"2025-08-01",{"name":5,"class":6}]